# RINVOQ LQ
> **NDA218347** · New Drug Application · Sponsor: ABBVIE · Approved 2024-04-26
## Drug
- **FDA Application Number:** NDA218347
- **Application type:** New Drug Application
- **Brand name:** RINVOQ LQ
- **Generic name:** UPADACITINIB
- **Active ingredients:** UPADACITINIB
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ABBVIE
- **Manufacturer:** AbbVie Inc.
- **First approval:** 2024-04-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218347)
---
*MORVS · CC0 1.0*